Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.
The Indianapolis-based health insurer increased its profit forecast after Obamacare enrollments boosted quarterly results.
The value of corporate takeovers announced in 2014 hit the $1 trillion mark Monday, reaching that level at the fastest pace in seven years.
Former Colts quarterback Peyton Manning has been passed as the top National Football League player when it comes to merchandise sales. Two Colts rank among the top 50.
The court noted that after the government filed a second indictment March 12, the trade-secret theft claims against Guoqing Cao and Shuyu Li were changed to wire fraud, and aiding and abetting and conspiracy to commit wire fraud.
Jack Ramsay, who won an NBA title with Portland and coached the Indiana Pacers from 1986 to 1988, died Monday in Naples, Fla., after battling cancer for more than 15 years, ESPN reported
The lawsuit is part of a movement by current and former college athletes to secure compensation, and greater medical benefits, control over their images and labor protections in a system that considers them amateurs.
The deal will help Zimmer, a maker of artificial hips and knees, take on Johnson & Johnson, the No. 1 manufacturer in the now-growing $45 billion market.
Orthopedic device maker Zimmer Holdings Inc. is buying privately-held competitor Biomet Inc. in a cash-and-stock deal between the Warsaw-based companies valued at about $13.35 billion.
The drugmaker, which is weathering patent expirations, saw sales fall more slowly than expected for its antidepressant Cymbalta.
The Indianapolis-based pharmaceutical maker gets a much-needed boost with FDA approval for gastric-cancer drug ramucirumab, which quickly could account for $1 billion in annual sales.
Indianapolis-based Calumet Specialty Products Partners LP plans to lower its leverage by increasing earnings rather than cutting debt that is rising by 35.6 percent this month.
Subaru, which added more U.S. market share than any international carmaker last year, is pushing ahead with U.S. expansion plans as it awaits a Toyota’s decision on whether it will keep building Camrys at Subaru’s Indiana plant.
StreetLinks, which sells real estate appraisal management services and software, will retain its brand name and remain headquartered in Indianapolis, according to the statement.
Republicans are searching for a candidate who can unite the party’s pro-business establishment with its small-government activists. Pence’s allies say the temperate-toned governor has a record that pleases both.
Texas Monthly, the award-winning magazine owned by Indianapolis-based Emmis Communications Corp., says the Times hired away its top editor to join the newspaper’s magazine division before his contract expired.
Former hedge-fund executives who left Wall Street are finding new ways to milk profits from old trailer parks, including one in Indianapolis.
WellPoint Inc. is leading companies that have poured $13.4 million into defeating a ballot initiative that would give California regulators the power to reject increases in health policy premiums.
California, the U.S. state with the largest population and budget, offers the least website access to its government spending data, according to a new study. Indiana provided the most information.
Takeda Pharmaceutical Co. and Eli Lilly and Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
